Multimodality Screening of Hepatic Nodules in Patients With Congenital Heart Disease After Fontan Procedure: Role of Ultrasound, ARFI Elastography, CT, and MRI

Carregando...
Imagem de Miniatura
Citações na Scopus
30
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
AMER ROENTGEN RAY SOC
Citação
AMERICAN JOURNAL OF ROENTGENOLOGY, v.211, n.6, p.1212-1220, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
OBJECTIVE. Currently, there is no consensus in the literature regarding the screening of hepatic nodules in patients who have undergone the Fontan procedure. The objectives of this study are to evaluate in this population the frequency of hepatic nodules at ultrasound (US), CT, and MRI; to measure liver stiffness using acoustic radiation force impulse (ARFI) elastography; and to investigate predictive factors for hepatic nodules. SUBJECTS AND METHODS. In this cross-sectional study, 49 patients who underwent the Fontan procedure were prospectively recruited from August 2014 through June 2016. These patients underwent clinical evaluation for hepatic disorders, ARFI elastography, US, CT, and MRI. RESULTS. Most of the patients had no symptoms, and hepatic nodules were detected in three of 49 (6.1%) patients at US, 14 of 44 (31.8%) patients at CT, and 19 of 48 (39.6%) patients at MRI. Liver stiffness at ARFI elastography was significantly higher in patients with hepatic nodules than i n patients without such nodules (2.64 +/- 0.81 m/s vs 1.94 +/- 0.49 m/s; p = 0.002) and was a significant predictor of hepatic nodule (AUC, 0.767; p = 0.002). No clinical or laboratory data had any significant correlation with the existence of hepatic nodules, including time since Fontan procedure. CONCLUSION. In our study, more than one-third of patients had hepatic nodules at CT or MRI, but US did not detect most hepatic nodules. Liver stiffness at ARFI elastography was significantly higher in patients with hepatic nodules, and it may help guiding which patient should be further imaged with CT or MRI.
Palavras-chave
CT, Fontan procedure, liver disease, MDCT, MRI, ultrasound
Referências
  1. Asrani SK, 2013, NEW ENGL J MED, V368, P1756, DOI 10.1056/NEJMc1214222
  2. Babaoglu K, 2010, PEDIATR CARDIOL, V31, P861, DOI 10.1007/s00246-010-9685-x
  3. Baumgartner H, 2010, EUR HEART J, V31, P2915, DOI 10.1093/eurheartj/ehq249
  4. Bhatt AB, 2015, CIRCULATION, V131, P1884, DOI 10.1161/CIR.0000000000000204
  5. Bradley Elisa, 2015, Curr Treat Options Cardiovasc Med, V17, P51, DOI 10.1007/s11936-015-0412-z
  6. Bryant T, 2011, INT J CARDIOL, V151, P268, DOI 10.1016/j.ijcard.2010.05.047
  7. Bulut OP, 2013, J PEDIATR-US, V163, P201, DOI 10.1016/j.jpeds.2012.12.071
  8. Camposilvan S, 2008, ANN THORAC SURG, V86, P177, DOI 10.1016/j.athoracsur.2008.03.077
  9. Daniels CJ, 2017, J AM COLL CARDIOL, V70, P3173, DOI 10.1016/j.jacc.2017.10.045
  10. Eipel C, 2010, WORLD J GASTROENTERO, V16, P6046, DOI 10.3748/wjg.v16.i48.6046
  11. Elsayes KM, 2017, RADIOGRAPHICS, V37, P1994, DOI 10.1148/rg.2017170098
  12. Ewe SH, 2009, CONGENIT HEART DIS, V4, P103, DOI 10.1111/j.1747-0803.2009.00255.x
  13. FONTAN F, 1971, THORAX, V26, P240, DOI 10.1136/thx.26.3.240
  14. FONTAN F, 1990, CIRCULATION, V81, P1520, DOI 10.1161/01.CIR.81.5.1520
  15. Friedrich-Rust M, 2008, J THORAC CARDIOV SUR, V135, P560, DOI 10.1016/j.jtcvs.2007.09.039
  16. Gewillig M, 2005, HEART, V91, P839, DOI 10.1136/hrt.2004.051789
  17. Ghaferi AA, 2005, J THORAC CARDIOV SUR, V129, P1348, DOI 10.1016/j.jtcvs.2004.10.005
  18. Guerin F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125493
  19. Huppertz A, 2005, RADIOLOGY, V234, P468, DOI 10.1148/radiol.2342040278
  20. Jacobs JP, 2013, WORLD J PEDIATR CONG, V4, P349, DOI 10.1177/2150135113494228
  21. Kendall TJ, 2008, J CLIN PATHOL, V61, P504, DOI 10.1136/jcp.2007.052365
  22. Khairy P, 2008, CIRCULATION, V117, P85, DOI 10.1161/CIRCULATIONAHA.107.738559
  23. Khairy P, 2007, CIRCULATION, V115, P800, DOI 10.1161/CIRCULATIONAHA.105.592378
  24. Kiesewetter CH, 2007, HEART, V93, P579, DOI 10.1136/hrt.2006.094516
  25. Kutty SS, 2014, HEPATOLOGY, V59, P251, DOI 10.1002/hep.26631
  26. Kwon S, 2015, J GASTROINTEST ONCOL, V6, pE55, DOI 10.3978/j.issn.2078-6891.2015.009
  27. Melero-Ferrer JL, 2014, WORLD J PEDIATR CONG, V5, P365, DOI 10.1177/2150135114530172
  28. Maisey NR, 2000, BRIT J CANCER, V83, P287, DOI 10.1054/bjoc.2000.1166
  29. OH C, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004823
  30. Ono M, 2006, EUR J CARDIO-THORAC, V30, P923, DOI 10.1016/j.ejcts.2006.08.025
  31. Pellicoro A, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S26
  32. Poterucha JT, 2015, MAYO CLIN PROC, V90, P882, DOI 10.1016/j.mayocp.2015.04.020
  33. Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742
  34. Rychik J, 2012, PEDIATR CARDIOL, V33, P1001, DOI 10.1007/s00246-012-0315-7
  35. Seale MK, 2009, RADIOGRAPHICS, V29, P1725, DOI 10.1148/rg.296095515
  36. Silversides CK, 2010, CAN J CARDIOL, V26, pE98, DOI 10.1016/S0828-282X(10)70356-1
  37. Surrey LF, 2016, HUM PATHOL, V57, P106, DOI 10.1016/j.humpath.2016.07.006
  38. Takuma Y, 2016, INTERNAL MED, V55, P3265, DOI 10.2169/internalmedicine.55.6869
  39. Valla DC, 2018, HEPATOL INT, V12, pS168, DOI 10.1007/s12072-017-9810-5
  40. Wallihan DB, 2013, PEDIATR RADIOL, V43, P330, DOI 10.1007/s00247-012-2531-y
  41. Yoo BW, 2014, J THORAC CARDIOV SUR, V148, P1498, DOI 10.1016/j.jtcvs.2014.04.010